{"schema_version":"secwatch.filing_event.v1","accession":"0000856982-25-000006","form_type":"8-K","ticker":"MMSI","cik":"0000856982","company_name":"MERIT MEDICAL SYSTEMS INC","filed_at":"2025-01-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.522986+00:00","generated_at":"2026-05-27T08:49:54.585283+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"Merit Medical hosts investor call on WRAPSODY CIE; prepared remarks truncated in filing","bullets":["Conference call held January 28, 2025, to discuss commercial and marketing updates for the WRAPSODY CIE stent-graft.","Participants include CEO Fred Lampropoulos, EVP R&D John Hall, VP Sales Caleb Konstanski, CFO Raul Parra, and CLO Brian Lloyd.","Dr. Danny Patel, a paid consultant interventional nephrologist, also spoke on the call.","Full content of prepared remarks not available in the furnished exhibit; specific financial or clinical metrics not disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0000856982-25-000006","json":"https://secwatch.observer/filing/0000856982-25-000006.json","markdown":"https://secwatch.observer/filing/0000856982-25-000006.md","text":"https://secwatch.observer/filing/0000856982-25-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/856982/000085698225000006/0000856982-25-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/856982/000085698225000006/mmsi-20250128x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T08:49:54.585283+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}